Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-46.91%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-46.91%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
Pasithea Therapeutics Corp fundamental performance
Across Pasithea Therapeutics Corp's full reported history, from 2021 to 2025, revenue declined from $ 15.06K to $ 0.00 and net income went from -$ 2M to -$ 20M. Revenue increased in 25% of the years measured; net income in 25%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.49 | — |
1 Year2025-08-12 | $ 0.70 | -30.00% |
All Time2021-09-15 | $ 71.20 | -99.31% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | All Time2021-09-15 |
|---|---|---|---|
| Price | $ 0.49 | $ 0.70 | $ 71.20 |
| Return | — | -30.00% | -99.31% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 20M | $ 55M |
| 2024 | $ 0.00 | -$ 13M | $ 6M |
| 2023 | $ 486.56K | -$ 15M | $ 16M |
| 2022 | $ 486.56K | -$ 13M | $ 33M |
| IPO2021 | $ 15.06K | -$ 2M | $ 52M |
Explore beyond KTTA
You're looking at Pasithea Therapeutics Corp. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
